跳至主要内容
临床试验/ACTRN12611000818932
ACTRN12611000818932尚未招募未知

Among Australians who have Diagnostic and Statistical Manual Fourth Edition(DSM IV) alcohol dependence , does acamprosate reduce cognitive impairment during withdrawal treatment when compared to placebo thus achieving the planned outcome of reducing the risk of neuro cognitive impairment during alcohol withdrawal

Drug and Alcohol Services South Australia0 个研究点目标入组 80 人开始时间: 2011年8月4日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
30 Years 至 100 Years(—)
性别
All

入选标准

  • 1.Aged 30 years or greater.
  • 2.Have a diagnosis of DSM IV Alcohol Dependence.
  • 3.Drinking alcohol >80gm daily in males and 60gms daily in females

排除标准

  • 1.Opiate, Stimulant, Cannabis, Inhalant or Benzodiazepine dependence.
  • 2.History of dementia or severe brain injury resulting in a mini mental score less than or equal to 26 out of 30
  • 3.Diagnosis of Wernicke’s Encephalopathy or Korsakoff’s Encephalopathy
  • 4.Receiving Acamprosate medication in the 28 days prior to admission
  • 5.Any history, clinical or biochemical indication of renal function impairment
  • 6.Pregnancy

研究者

发起方
Drug and Alcohol Services South Australia

相似试验

招募中
不适用
Measurement and evaluation of thiamine concentrations in the blood of Australians who have a history of Diagnostic and Statistical Manual Fourth Edition(DSM IV) alcohol dependence or abuse, after 20 years of supplementing flour with thiamine.Wernicke-Korsakoff syndromeAlcohol AbuseNeurological - DementiasMental Health - AddictionPublic Health - EpidemiologyAlcohol DependenceThiamine Deficiency
ACTRN12610000661077Dr Philip Crowley, M.B.B.S., F.R.A.C.G.P., Grad. Dip. Mgt., Trainee R.A.C.P. Chapter of Addiction Medicine, Senior Medical Officer, Drug and Alcohol Services South Australia180
已完成
不适用
Changes in troponin for diagnosis of acute myocardial infarction (AMI) in an emergency department (ED) population with chest pain.Cardiovascular - Coronary heart diseaseAcute coronary syndrome
ACTRN12610000052033Queensland Emergency Medicine Research Foundation QEMRF650
尚未招募
不适用
Free Jab (COVID-19) Control group in AustraliaHealth and risk outcomes for Australians who not intending to receive the COVID-19 vaccination.ot vaccinated against COVID-19Not planning to receive COVID-19 vaccinationsNot vaccinated against COVID-19Infection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesInflammatory and Immune System - Normal development and function of the immune system
ACTRN12621001513808Sylvia Smart1,000
已完成
不适用
The Australian Ultraviolet Radiation and Immunity StudyImpact of solar ultraviolet radiation on human primary immune response to immunisation with a T-cell dependent antigen (Keyhole Limpet Hemocyanin or KLH)Inflammatory and Immune System - Normal development and function of the immune system
ACTRN12610000234011Dr Robyn Lucas210
招募中
不适用
The Duchenne Registry AustraliaBecker muscular dystrophymanifesting carriers of Duchennecarriers of Duchenne or Becker muscular dystrophy (asymptomatic)Duchenne muscular dystrophy
ACTRN12617000690358Save Our Sons Duchenne Foundation1,000
A controlled trial of Acamprosate to reduce the... | 临床试验